Shannon Grant

Shannon Grant

Fred Hutchinson Cancer Research Center - Seattle / United States
Others
AD Scientific Index ID: 4632202
person_outline Shannon Grant's MOST POPULAR ARTICLES
1-) Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trialLG Bekker, Z Moodie, N Grunenberg, F Laher, GD Tomaras, KW Cohen, ...The Lancet HIV 5 (7), e366-e378, 2018952018
2-) Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trialG Pantaleo, H Janes, S Karuna, S Grant, GL Ouedraogo, M Allen, ...The Lancet HIV 6 (11), e737-e749, 2019352019
3-) Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trialY Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ...The Journal of infectious diseases 217 (8), 1280-1288, 2018442018
4-) Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High …KK Teo, LB Goldstein, BR Chaitman, S Grant, WS Weintraub, ...Stroke 44 (10), 2688-2693, 2013422013
5-) Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC …F Laher, Z Moodie, KW Cohen, N Grunenberg, LG Bekker, M Allen, ...PLoS medicine 17 (2), e1003038, 2020372020